Thunder Biotech

📍 Provo, United States🗓 Founded 2016👥 15 employees💰 Last funded Jan 2021
Biotechnology Research🌐 thunderbiotech.com
Website LinkedIn
Thunder Biotech, Inc. is an immune-oncology company developing patented MOTO-CAR™ technology - genetically engineered CAR macrophages - that help cancer patients immune cells recognize and attack solid tumors. Traditional cancer treatments— like surgery, radiation, and chemotherapy—are often ineffective, invasive, and difficult to tolerate. Thunder Biotech is designing MOTO-CAR™s to be a more effective and humane therapy. Thunder Biotechs MOTO-CAR™s re-educate Tumor Associated Macrophages and restore their M1 ability to recognize and eliminate tumor cells. In addition, MOTO-CAR™s are armed with tumor specific receptors that directly adhere to the tumor cell surface allowing them to initiate tumor cell destruction and recruit the natural T cell response engaging them to eliminate the tumor. This T cell response will then provide the body with a memory response preventing tumor recurrence.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Thunder Biotech?
Thunder Biotech has 1 investors on record on gritt.io, 1 mid-stage.
When did Thunder Biotech last raise funding?
The most recent investment in Thunder Biotech recorded on gritt.io was in January 2021.
When was Thunder Biotech founded?
Thunder Biotech was founded in 2016.
What industry is Thunder Biotech in?
Thunder Biotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Thunder Biotech based?
Thunder Biotech is headquartered in Provo, United States.